Company Focus
AbbVie
Latest AbbVie News
Biotechnology
The Amsterdam District Court has delivered a ruling in the lawsuit brought by Farma ter Verantwoording (FtV) — The Pharmaceutical Accountability Foundation— against US drugmaker AbbVie. 14 July 2025
Related News
Insights
Company Spotlight
A Swedish biotechnology company that specializes in the development of pharmaceuticals for various types of cancer and autoimmune/inflammatory diseases.
Latest News & Features of interest to AbbVie
Pharmaceutical
Shares in US healthcare conglomerate Johnson & Johnson rose by 6% during Wednesday morning’s trading after the presentation of its second-quarter financial results and latest guidance for 2025. 16 July 2025
Biotechnology
UK pharma major GSK is seeking US approval for Blenrep (belantamab mafodotin) in two multiple myeloma indications. 16 July 2025
Biotechnology
Canada and USA-based oncology biotech Repare Therapeutics has entered into an exclusive worldwide licensing agreement with privately-held Swiss firm Debiopharm International to establish tomorrow’s standards of care to cure cancer and infectious diseases, for lunresertib, a first-in-class precision oncology PKMYT1 inhibitor. 16 July 2025
Biotechnology
Japanese drugmaker JCR Pharmaceuticals has entered into a joint collaboration, option and license agreement with US biotech Acumen Pharmaceuticals to develop a novel therapeutic candidate for the treatment of Alzheimer’s disease (AD), enabled by JCR’s proprietary blood-brain barrier (BBB)-penetrating technology platform, J-Brain Cargo 16 July 2025
Biotechnology
Sino Biopharmaceutical is acquiring the remaining stake in Chinese biotech LaNova Medicines, setting the stage for deeper expansion into the competitive cancer immunotherapy market. 16 July 2025
Biotechnology
The USA's Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report assessing the comparative clinical effectiveness and value of Sanofi’s tolebrutinib for the treatment of secondary progressive multiple sclerosis (SPMS). 15 July 2025
Pharmaceutical
Russia will begin commercial production of a new anticancer vaccine, which massive supplies for the needs of domestic patients may begin already during the period of 2025-2026, reports The Pharma Letter’s local correspondent. 15 July 2025
Biotechnology
US biotech Tract Bio has appointed Chris Galloway as chief medical and development officer, as it prepares for an investigational new drug filing for its lead oncology candidate, TP-101, within the next 18 months. The Boston-based company is also expanding its board with two senior figures from the oncology and biotech world: Mark Adler and Kristiina Vuori. 15 July 2025
Biotechnology
Swiss clinical-stage CNS disease specialist Synendos Therapeutics has named Dr George Garibaldi as its chief medical officer (CMO). 15 July 2025
Pharmaceutical
The Bristol Myers Squibb subsidiary RayzeBio has opened a new 77,000-square-foot facility in Indianapolis, Indiana. 15 July 2025
Latest In Brief for AbbVie
Biotechnology
US biotech Nanoscope Therapeutics has begun a rolling submission to the American medicines regulator for MCO-010, the first gene-agnostic therapy seeking approval for retinitis pigmentosa (RP). 15 July 2025
Latest Related Ones To Watch News
Sino Biopharmaceutical is acquiring the remaining stake in Chinese biotech LaNova Medicines, setting the stage for deeper expansion into the competitive cancer immunotherapy market. 16 July 2025
30 June 2025
16 June 2025
Related Ones to Watch Companies
Refine Search
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze